Express Scripts Holding ROE 2006-2018 | ESRX

Current and historical return on equity (ROE) values for Express Scripts Holding (ESRX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Express Scripts Holding ROE for the three months ending September 30, 2018 was 25.43%.
Express Scripts Holding ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $4.90B $20.57B 25.61%
2018-06-30 $4.67B $19.38B 25.99%
2018-03-31 $4.60B $18.45B 26.93%
2017-12-31 $4.52B $18.13B 27.50%
2017-09-30 $3.63B $15.92B 22.71%
2017-06-30 $3.51B $15.75B 22.07%
2017-03-31 $3.43B $15.93B 21.68%
2016-12-31 $3.41B $16.24B 21.93%
2016-09-30 $2.74B $15.61B 17.35%
2016-06-30 $2.68B $15.41B 16.72%
2016-03-31 $2.56B $14.85B 15.86%
2015-12-31 $2.48B $17.38B 14.08%
2015-09-30 $2.29B $16.55B 12.51%
2015-06-30 $2.21B $15.83B 11.50%
2015-03-31 $2.12B $20.62B 10.43%
2014-12-31 $2.01B $20.06B 9.72%
2014-09-30 $1.93B $20.17B 9.14%
2014-06-30 $1.77B $20.46B 8.06%
2014-03-31 $1.80B $21.89B 7.88%
2013-12-31 $1.85B $21.85B 7.93%
2013-09-30 $1.85B $23.72B 7.81%
2013-06-30 $1.81B $23.88B 7.74%
2013-03-31 $1.42B $23.63B 6.17%
2012-12-31 $1.31B $23.40B 7.39%
2012-09-30 $1.10B $22.75B 8.77%
2012-06-30 $1.03B $22.13B 13.99%
2012-03-31 $1.22B $2.78B 52.66%
2011-12-31 $1.28B $2.48B 48.93%
2011-09-30 $1.32B $2.17B 45.52%
2011-06-30 $1.29B $1.83B 40.99%
2011-03-31 $1.25B $3.96B 34.61%
2010-12-31 $1.18B $3.61B 33.48%
2010-09-30 $1.08B $3.22B 30.57%
2010-06-30 $0.97B $3.65B 27.44%
2010-03-31 $0.87B $3.65B 25.69%
2009-12-31 $0.83B $3.55B 29.42%
2009-09-30 $0.81B $3.31B 36.99%
2009-06-30 $0.82B $3.08B 51.52%
2009-03-31 $0.81B $1.30B 83.99%
2008-12-31 $0.78B $1.08B 92.68%
2008-09-30 $0.71B $0.87B 95.45%
2008-06-30 $0.65B $0.63B 98.41%
2008-03-31 $0.61B $0.78B 90.77%
2007-12-31 $0.57B $0.70B 70.95%
2007-09-30 $0.58B $0.54B 63.46%
2007-06-30 $0.55B $0.69B 53.94%
2007-03-31 $0.50B $1.29B 45.64%
2006-12-31 $0.48B $1.13B 40.03%
2006-09-30 $0.44B $0.97B 34.53%
2006-06-30 $0.43B $1.03B 31.28%
2006-03-31 $0.42B $1.62B 28.81%
2005-12-31 $0.40B $1.47B 28.98%
Sector Industry Market Cap Revenue
Medical Medical Services $55.371B $100.065B
Express Scripts Holding Company puts medicine within reach of tens of millions of people by aligning with plan sponsors, taking bold action and delivering patient-centered care to make better health more affordable and accessible. Headquartered in St. Louis, Express Scripts provides integrated pharmacy benefit management services, including network-pharmacy claims processing, home delivery pharmacy care, specialty pharmacy care, specialty benefit management, benefit-design consultation, drug utilization review, formulary management, and medical and drug data analysis services. Express Scripts also distributes a full range of biopharmaceutical products and provides extensive cost-management and patient-care services.
Stock Name Country Market Cap PE Ratio
ICON (ICLR) Ireland $7.464B 23.39
PRA Health Sciences (PRAH) United States $6.655B 27.17
Charles River Laboratories (CRL) United States $6.430B 22.55
HealthEquity (HQY) United States $5.667B 118.62
Premier (PINC) United States $5.378B 18.33
INC Research Holdings (SYNH) United States $5.176B 20.89
Teladoc (TDOC) United States $4.246B 0.00
NovoCure (NVCR) Jersey $2.842B 0.00
AMN Healthcare Services Inc (AMN) United States $2.708B 18.58
Medpace Holdings (MEDP) United States $2.063B 25.52
BioTelemetry (BEAT) United States $2.054B 36.28
Healthways (TVTY) United States $1.488B 18.31
Intrexon (XON) United States $1.372B 0.00
IKang Healthcare (KANG) China $1.081B 53.69
CareDx (CDNA) United States $1.071B 0.00
Natera (NTRA) United States $0.969B 0.00
China Cord Blood (CO) China $0.801B 21.26
Surgery Partners (SGRY) United States $0.685B 0.00
Apollo Medical Holdings (AMEH) United States $0.612B 0.00
Civitas Solutions (CIVI) United States $0.525B 10.34
Establishment Labs Holdings (ESTA) $0.512B 0.00
OncoCyte (OCX) United States $0.074B 0.00
Interpace Diagnostics (IDXG) United States $0.042B 0.00
Cancer Genetics (CGIX) United States $0.016B 0.00
OpGen (OPGN) United States $0.008B 0.00
FORM Holdings (XSPA) United States $0.004B 0.00
Biocept (BIOC) United States $0.004B 0.00